Amy Pfeiffer

Ms. Pfeiffer leads business operations, finance and administration for Vivace. Prior to joining the company, she served in a number of accounting, administrative and operational roles for Afferent Pharmaceuticals, which was acquired by Merck. Prior to joining Afferent, Ms. Pfeiffer worked with Dr. Qiao and Dr. Post at LEAD Therapeutics, established and managed the business operations infrastructure, until it was acquired by BioMarin. She also has held key administrative roles with Acologix and ProteomTech. Ms. Pfeiffer holds a B.S. from San Francisco State University and an MBA from Golden Gate University.